| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.007 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |